Bovine lactoferrin's antiviral activity against adenoviruses was mediated through its heparin-interacting sites, which block virus attachment to cell surface glycosaminoglycans — a mechanism applicable to other heparin-binding viruses.
Universal blockLactoferrin blocks viral entry by competing for heparan sulfate binding sites — the same mechanism works against multiple virus types
What the researchers found
Lactoferrin's anti-adenovirus activity was mediated through its heparin-interacting domains, which compete with viral attachment to cell surface heparan sulfate — a mechanism explaining its broad antiviral spectrum against heparan sulfate-binding viruses.
Why it matters
Many important viruses (adenovirus, herpes, HPV, some coronaviruses) use heparan sulfate for cell entry. A natural protein that blocks this universal attachment mechanism has broad antiviral potential.
How the study worked
In-vitro antiviral study. Bovine lactoferrin and domain-modified variants tested against adenovirus infection. Heparin competition and binding site mutation experiments to determine the mechanism.
What this study cannot tell us
In-vitro mechanism study with adenovirus. The concentrations needed for in-vivo antiviral protection are uncertain.
How to read the evidence
Preliminary in-vitro evidence with clear mechanistic dissection of lactoferrin's antiviral action.
When this study was published
Published in 2003. Lactoferrin's broad antiviral mechanism through heparan sulfate competition has been confirmed for multiple viruses including SARS-CoV-2.
The bigger picture
A single natural protein that blocks viral cell entry through a universal mechanism could serve as a broad-spectrum antiviral — not just against adenovirus but any virus using heparan sulfate.
Questions still open
- Could lactoferrin prevent multiple viral infections simultaneously?
- Do nasal or oral lactoferrin supplements reduce viral infections?
- Can the heparin-binding domain be isolated as a smaller antiviral peptide?
Common questions
Can lactoferrin fight viruses?
Does this apply to COVID?
Read the original research
Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.
Journal of medical virology, 69(4), 495-502
Citation
Di Biase, Assunta Maria; Pietrantoni, Agostina; Tinari, Antonella; Siciliano, Rosa; Valenti, Piera; Antonini, Giovanni; Seganti, Lucilla; Superti, Fabiana. (2003). Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.. Journal of medical virology, 69(4), 495-502.